wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q47278103-69995B32-BE39-4382-8B23-4E8CC6D6EE27
Q47278103-69995B32-BE39-4382-8B23-4E8CC6D6EE27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47278103-69995B32-BE39-4382-8B23-4E8CC6D6EE27
The development of PARP as a successful target for cancer therapy.
P2860
Q47278103-69995B32-BE39-4382-8B23-4E8CC6D6EE27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47278103-69995B32-BE39-4382-8B23-4E8CC6D6EE27
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
226595d8061d1002cc5c589effc35b6622c89af7
P2860
A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group study